MedTrace Logo

Gestational Diabetes Monitoring and Management

NCT06963528 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2025-05-18

No results posted yet for this study

Summary

The primary goal is to predict the clinical outcomes of mother and baby using blood glucose and other routinely collected clinical data in pregnancy to predict adverse outcomes at birth in women with GDM. The secondary goal is to develop models to predict optimal blood glucose testing schedules for pregnant women. Exploratory Objectives are (1) to understand patterns of dosage and / or medication choice and (2) to describe different phenotypes of gestational diabetes based on multiple data input.

Conditions

  • Gestational Diabetes
  • Pregnancy Complications
  • Pregnancy in Diabetic
  • Pregnancy, High Risk
  • Diabetes Complications
  • Pregnancy Induced Hypertension
  • Pregnancy Weight Gain
  • Gestational Hypertension
  • Gestational Weight Gain
  • Gestational Diabetes Mellitus in Pregnancy
  • Gestational Complication
  • Gestational Mother
  • Pregnancy Preterm
  • Pregnancy Bleeding
  • Pregnancy Loss
  • Birth Weight
  • Birth Outcome, Adverse
  • Birth, Preterm
  • Birth Hypoxia

Sponsors & Collaborators

  • Royal Academy of Engineering

    collaborator UNKNOWN

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Huiiq Yvonne Lu · University of Oxford

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2023-09-01
Completion
2025-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06963528 on ClinicalTrials.gov